The Cooper Companies, Inc. (0I3I)
LSE
Closed
Oct 7, 2026
Day's Range
54.7752 wk Range
51.02Overview - 0I3I - The Cooper Companies, Inc.
Key Statistics
Valuation
Enterprise Value
13.16B
P/E (Trailing)
‪0.02‬
Price / Book
‪1.26‬
EV / EBITDA
‪14.12‬
Profitability
Profit Margin
‪13.46%‬
Operating Margin
‪20.82%‬
Return on Assets
‪2.73%‬
Return on Equity
‪6.83%‬
Ownership
Shares Outstanding
49.13M
Float
188.76M
Held by Insiders
‪0.63%‬
Held by Institutions
‪111.92%‬
Price stats
Beta
‪0.81‬
50-Day Avg
‪95.76‬
200-Day Avg
‪90.81‬
Dividends
Frequency
Semi-Annual
Market Cap - 0I3I - The Cooper Companies, Inc.
Peers - 0I3I - The Cooper Companies, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on LSE.
Profile Summary - 0I3I - The Cooper Companies, Inc.
About
The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. Through its CooperVision segment, the company develops, manufactures, and markets a broad range of contact lenses, including daily disposable, toric, multifocal, and specialty products designed to support different…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
